Meet the Researcher: Nicola McCarthy, Milner Therapeutics Institute
Drug Discovery World
JULY 3, 2024
NM: So, what we’re interested in the Milner is basically partnering between pharma and academia. We have a big consortium agreement that, at the moment, involves 14 pharma companies. NM: I think it’s moving into primary tissue, certainly for the wet lab work that we do on the arrayed functional genomics.
59 
Let's personalize your content